Industry Voices—The GLP-1 status quo is no longer acceptable, but it is changeable. Fierce healthcare
Author: admin
The rise of the Ozempic menu and how weight-loss drugs are changing dining out – The Independent
The rise of the Ozempic menu and how weight-loss drugs are changing dining out The Independent
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts – Chicago Sun-Times
Weight loss drugs like Ozempic a boon for Streeterville plastic surgery clinic, boosting demand for facelifts Chicago…
Is your weight loss drug affecting your relationship? – The Indian Express
Is your weight loss drug affecting your relationship? The Indian Express
The trillion-dollar opportunity in women’s health
Closing the gap in health interventions between men and women could add $1tn to the global…
FDA ODD given to Plus Therapeutics’ injectable radiotherapy
The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.
Why don’t celebrities admit to taking Ozempic? Expert answers at India Today Conclave – India Today
Why don’t celebrities admit to taking Ozempic? Expert answers at India Today Conclave India Today
New weight loss drugs spike Pa.’s Medicaid costs, lawmakers question use – 90.5 WESA
New weight loss drugs spike Pa.’s Medicaid costs, lawmakers question use 90.5 WESA
Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial – Nature.com
Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial Nature.com
Wegovy’s price cut, Amgen’s Ozempic competitor, and Big Pharma’s tax cut: Pharma news roundup – Quartz
Wegovy’s price cut, Amgen’s Ozempic competitor, and Big Pharma’s tax cut: Pharma news roundup Quartz